beta

ACST

Acasti Pharma Inc.

Acst

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Acasti Pharma Inc is a biopharmaceutical company. The Company is engaged in the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of cardiometabolic disorders.

Market Cap: 28.3 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.acastipharma.com

Shares Outstanding: 24.8 Million

Float: 24.8 Million

Dividend: 0.0 (0.0%)

Beta: 1.664063

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 48.7 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1561 trading days

From: 2013-08-05 To: 2019-10-18

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2015-10-15 10.0 1.0 10.0
Data provided by IEX Cloud